Challenges of equitable access to device-aided therapies for advanced Parkinson’s Disease in Poland — expert consensus and treatment recommendations

INTRODUCTION: In Poland, not all forms of device-aided therapies for advanced Parkinson's Disease (APD) are currently available. MATERIAL AND METHODS: We aimed to produce a consensus recommendation from Polish movement disorders experts after discussing gaps in the APD care pathway in Poland. RESULTS: Rescue therapy with apomorphine (APO) PEN injection and levodopa-entacapone-carbidopa intestinal gel infusion are not included in Poland's Specialist Therapeutic Programme, and are thus not reimbursed. For APO infusion, only the medication is reimbursed but not the device. CONCLUSIONS: Consensus expert opinion is that APD patients in Poland would benefit from additional reimbursement access to these treatment options to improve APD patient care.